LexDanaLexDanabeta
Inventor

MICHAEL J. MUNCHHOF

Inventor
US

Overview

4→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07BGeneral methods of organic chemistry14%
PatentTitleYear
11,970,485RET kinase inhibitors202411,964,968Compounds useful for inhibiting RET kinase202411,697,647RET kinase inhibitors202311,613,533Compounds useful for inhibiting RET kinase2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to LILLY CO ELI (4)· patent assignee history
2023–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LILLY CO ELI42023–2024
Locations
LocationPatentsSpan
US42023–2024